Dasatinib‐induced hypoglycemia in a patient with acute lymphoblastic leukemia

Abstract

Abstract Tyrosine kinase inhibitors can cause significant hypoglycemia in patients with diabetes on other antihyperglycemic medications. These patients should be monitored, and their medications adjusted accordingly.

Keywords

• acute lymphoblastic leukemia
• adverse effect
• diabetes
• hypoglycemia
• tyrosine kinase inhibitor